Showing results (61-70 of 104) with videos related to
Sort By:
Pageof 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Expression of human endogenous retrovirus k envelope transcripts in human breast cancerF Wang-Johanning, A R Frost, G L Johanning, et al.Cancer Biotherapy & Radiopharmaceuticals|April 1, 1997
Correlation of toxicity with treatment parameters for 131I-CC49 radioimmunotherapy in three phase II clinical trialsT Liu, R F Meredith, M N Saleh, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1997
Adenoviral-mediated delivery of gastrin-releasing peptide receptor results in specific tumor localization of a bombesin analogue in vivoM E Rosenfeld, B E Rogers, M B Khazaeli, et al.Cancer Biotherapy & Radiopharmaceuticals|October 27, 2005
Phase I study of 90Y-CC49 monoclonal antibody therapy in patients with advanced non-small cell lung cancer: effect of chelating agents and paclitaxel co-administrationAndres Forero, Ruby F Meredith, M B Khazaeli, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Phase II study of interferon-enhanced 131I-labeled high affinity CC49 monoclonal antibody therapy in patients with metastatic prostate cancerR F Meredith, M B Khazaeli, D J Macey, et al.Gene Therapy|July 1, 1996
Enhancement of radiolabeled antibody binding and tumor localization through adenoviral transduction of the human carcinoembryonic antigen geneD Raben, D J Buchsbaum, M B Khazaeli, et al.Proceedings of the National Academy of Sciences of the United States of America|June 1, 1989
Mouse/human chimeric monoclonal antibody in man: kinetics and immune responseA F LoBuglio, R H Wheeler, J Trang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
Intraperitoneal pretarget radioimmunotherapy with CC49 fusion proteinDonald J Buchsbaum, M B Khazaeli, Donald B Axworthy, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1997
Localization of iodine-125-mIP-Des-Met14-bombesin (7-13)NH2 in ovarian carcinoma induced to express the gastrin releasing peptide receptor by adenoviral vector-mediated gene transferB E Rogers, M E Rosenfeld, M B Khazaeli, et al.Gene Therapy|December 1, 1996
Approaches to enhance cancer radiotherapy employing gene transfer methodsD J Buchsbaum, D Raben, M A Stackhouse, et al.Pageof 11